Mayra Ramos

Use of the Humanized Anti-Epidermal Growth Factor Receptor Monoclonal Antibody h-R3 in Combination With Radiotherapy in the Treatment of Locally Advanced Head and Neck Cancer Patients

Tania Crombet, Marta Osorio, Teresa Cruz et al. · Journal of Clinical Oncology · 2004 · 298 citations · Full text

Treatment of high-grade glioma patients with the humanized anti-epidermal growth factor receptor (EGFR) antibody h-R3: Report from a phase I/II trial

Tania Crombet, Javier Figueredo, Mauricio Catalá et al. · Cancer Biology & Therapy · 2006 · 161 citations · Full text

Phase I single-dose study of intracavitary-administered Nimotuzumab labeled with 188-Re in adult recurrent high-grade glioma

Á. Casacó, G. López, Iván García et al. · Cancer Biology & Therapy · 2008 · 87 citations · Full text

Treatment of malignant, non-resectable, epithelial origin esophageal tumours with the humanized anti-epidermal growth factor antibody nimotuzumab combined with radiation therapy and chemotherapy.

Mayra Ramos, Patricia Lorenzo-Luaces, N González Lazo et al. · Cancer Biology & Therapy · 2012 · 68 citations · Full text

Phase I Clinical Evaluation of a Neutralizing Monoclonal Antibody Against Epidermal Growth Factor Receptor in Advanced Brain Tumor Patients: Preliminary Study

Tania Crombet, Olga Torres, Vanina Rodríguez et al. · Hybridoma · 2001 · 59 citations

Brain Tumor Patients, Immunology, Pathology +18